Canadian Journal of Infectious Diseases and Medical Microbiology

Research Article

Isolation of Extended-Spectrum β-lactamase- (ESBL-) Producing Escherichia coli and Klebsiella pneumoniae from Patients with Community-Onset Urinary Tract Infections in Jimma University Specialized Hospital, Southwest Ethiopia

Table 4

Resistance profiles of isolates from healthcare-associated versus true community-acquired in JUSH, Southwest of Ethiopia.


Antibiotics	Total R (N%)	Healthcare-associated		Community-acquired		value
Antibiotics	R	R	S	R	S	value

Cefotaxime	18 (24.3%)	9 (36%)	16 (64%)	9 (18.4%)	40 (81.6%)	0.168
Ceftriaxone	17 (23.0%)	9 (36%)	16 (64%)	9 (18.4%)	40 (81.6%)	0.168
Ceftazidime	16 (21.6%)	9 (36%)	16 (64%)	7 (14.3%)	42 (85.7%)	0.041
AMC	27 (36.5%)	10 (40%)	15 (60%)	17 (36.7%)	32 (65.3%)	0.799
Cephalothin	53 (71.6%)	18 (72%)	7 (28%)	35 (71.4%)	14 (28.6%)	1.000
Ampicillin	74 (100%)	25(100%)	0	49 (100%)	0	—
Gentamicin	17 (23%)	9 (36%)	16 (64%)	8 (16.3%)	41(83.7%)	0.080
Amikacin	7 (9.5%)	4 (16%)	21 (84%)	3 (6.1%)	46 (93.9%)	0.217
NA	38 (51.4%)	14 (56%)	11 (44%)	24 (49%)	25 (51%)	0.628
CIP	24 (32.4%)	9 (36%)	16 (64%)	15 (30.6%)	34 (69.4%)	0.793
Norfloxacin	23 (31.1%)	9 (36%)	16 (64%)	14 (28.6%)	35 (71.4%)	0.793
SXT	41 (55.4%)	15 (60%)	10 (40%)	26 (53.1%)	23 (46.9%)	1.000
Tetracycline	45 (60.8%)	14 (56%)	11 (44%)	31 (54.4%)	18 (45.6%)	0.610
C	30 (40.5%)	14 (56%)	11 (44%)	16 (32.6%)	33 (67.4%)	0.079
Imipenem	0	0	25 (100%)	0	49 (100%)	—

R: resistant, S: sensitive, AMC: amoxicillin-clavulanic acid, NA: nalidixic acid, CIP: ciprofloxacin, SXT: trimethoprim-sulfamethoxazole, C: chloramphenicol.